Filing Details
- Accession Number:
- 0001209191-15-022207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 16:08:49
- Reporting Period:
- 2015-03-02
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 16:08:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585018 | W. Robert Hesslein | 150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-02 | 10,934 | $4.16 | 71,059 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-02 | 3,125 | $7.12 | 74,184 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-02 | 1,424 | $48.35 | 72,760 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-02 | 10,934 | $0.00 | 10,934 | $4.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-02 | 3,125 | $0.00 | 3,125 | $7.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,066 | 2023-03-07 | No | 4 | M | Direct | |
| 9,375 | 2023-05-21 | No | 4 | M | Direct |
Footnotes
- The sale of these shares was made in a sell-to-cover transaction to cover the exercise price for the exercise of stock options.
- This option was granted on March 7, 2013 and vests in equal quarterly installments over a four-year period beginning on June 7, 2013.
- This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.
Billionaire Hedge Funds
